Abstract
The results are presented of phytochemical investigations, during the last decade, of some wild-growing species of the family Gentianaceae from Serbia and Montenegro. Some of the species investigated, members of the genera Gentiana, Gentianella, and Swertia, are endemic, and the emphasis in this report is on those exhibiting biological activities that could be regarded as a potential source of drugs. This review discusses more than fifty compounds, such as xanthones, secoiridoids, and C-glucoflavonoids.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
14.1 Introduction
The process that leads from plants to bioactive pure constituents requires multidisciplinary collaboration. This review summarizes the last two decades of results on Gentianaceae species of the rich Serbian and Montenegrin flora. In the search for biologically active and new compounds, targeted collection of wild-growing plants with special emphasis on endemics was based on chemotaxonomic and ethnomedicinal information of the corresponding genera. Combined efforts led to the isolation and structure elucidation of biologically active secondary metabolites, mostly belonging to three types of chemical structures, typical of the Gentianaceae, i.e., xanthones, flavone C-glycosides and secoiridoids (Šavikin-Fodulovic et al. 2002).
14.2 Genus Gentiana
Gentiana L. is a large cosmopolitan genus with about 400 species, occurring in alpine habitats of temperate regions of Asia, Europe, and the Americas. In the central regions of the Balkan Peninsula can be found 11 species of the genus Gentiana , such as G. lutea , G. punctata , G. cruciata , G. asclepiadea , G. pneumonanthe , G. kochiana , G. dinarica , G. verna , G. tergestina, G. utriculosa , and G. nivalis (Jovanović-Dunjić 1973). The best known is yellow gentian, G. lutea L., distributed in both Serbia and Montenegro.
14.2.1 Gentiana lutea L. (Yellow Gentian)
Gentiana lutea (Fig. 14.13a) is very popular as a stomachic as well as a component in preparations showing beneficial effects in gall bladder and liver diseases (Blumenthal 1998; Tasic et al. 2004). The roots and rhizome of G. lutea (Gentianae radix) are described in European Pharmacopoeia 7.0 (Ph. Eur. 7.0), (2011) as well as in many national pharmacopoeias (Pharmacopoea Yugoslavica 1984). The material is stabilized (unfermented), yellow colored, and very bitter. It is also used in traditional medicine, and in the course of his ethnomedicinal studies , the Serbian pharmacognosist Tucakov (1996) concluded that the yellow gentian root is among the most important remedies of the mountain inhabitants in Serbia. The fermented root, with a maroon-colored cross section, exhibiting a smell and taste like dried figs, is used for preparing alcoholic beverages (Tasic et al. 2004). Some studies showed that the root possesses cholagogue, anthelmintic , anti-inflammatory, and antimicrobial activity (Öztütk et al. 1998; Pontus et al. 2006; Menković et al. 1999; Šavikin et al. 2007). Underground organs of yellow gentian are characterized as having a diverse chemical composition, with secoiridoids as the main constituents. LC-ESI TOF MS chromatogram of G. lutea underground organs collected on Mountain Suvobor, Serbia, is presented in Fig. 14.1 with a tentative identification of the compounds in Table 14.1.
The bitter taste of the roots originates from secoiridoids . Among them, the most abundant are 1–3.
In addition, the roots contain biphenyl derivatives such amarogentin (5) located in bark of the roots, as well as the closely related amaropanin (4) and amaroswerin (6). Amarogentin is one of the most bitter natural compounds known (Wagner et al. 1983).
Another group of pharmacologically active constituents are xanthones 7–9.
The aerial parts of yellow gentian showed themselves to be very interesting and promising plant material (Menković et al. 2000). LC-ESI TOF MS chromatogram of G. lutea leaves collected from plants on the Mount Suvobor, Serbia, is presented in Fig. 14.2 with details of the compounds in Table 14.2.
The presence of 8 (Menković et al. 2000) and two flavonoid heterosides, 10 and 11, was reported in the leaves of G. lutea by Hostettmann et al. (1973).
From the aerial parts of G. lutea , three types of secondary metabolites, including xanthones, flavonoids, and secoiridoids were isolated in the laboratories of the authors of this chapter.
Xanthones
C-Glucoxanthone mangiferin (12) was accompanied by gentioside (9) and isogentisin (8).
C-Glucoflavones
The aerial parts of G. lutea contained C-glucoflavones 13–15:
Secoiridoids
The aerial parts of G. lutea yielded seven secoiridoids, namely 1–3 and 16–19:
14.2.2 Gentiana dinarica Beck
Gentiana dinarica (Fig. 14.13b) is a rare, endemic, perennial species distributed in the Apennine and Balkan Peninsula. It grows on carbonate soils in subalpine and alpine regions at an altitude of 800–2300 m. According to authors’ knowledge, it is not used in traditional medicine. In their investigations, plant materials (aerial parts and roots) were collected on the Mount Tara (1300 m), Serbia. A LC-ESI TOF MS chromatogram of G. dinarica leaves is presented in Fig. 14.3 with compounds identified in Table 14.3. The aerial parts of G. dinarica contained secoiridoids and C-glucoflavones, but xanthones were absent. Three C-glucoflavones, 13, 15, and 10, were isolated from aerial parts.
A methanolic root extract contained three xanthones, namely 20–22 and two C-glucoflavones 13 and 10. Xanthone aglycones were absent. Secoiridoid components isolated both from roots and from aerial parts were 1–3 and 5. Considerable amount of compound 5 was found in the roots, which could be of interest.
14.2.3 Gentiana kochiana E.P. Perrier and Songeon (Syn. G. acaulis L.)
Gentiana kochina (Fig. 14.13c) is a small gentian native to Central and Southern Europe, from Spain east to the Balkans, growing especially in the mountainous regions, such as the Alps, Cevennes, and Pyrenees, at an elevation of 800–3000 m. It grows in the mountain meadows with acidic silicate soil, inhabiting mostly south aspects. Extracts of this plant are used in traditional medicine in Tuscany (Italy) as an antihypertensive remedy (Manganelli et al. 2000).
The aerial parts and/or roots collected on the Mount Komovi, Montenegro, contained exclusively 1,3,7,8-tetraoxygenated xanthones, such as 23, its 1-O-primeveroside (24), 25 and gentiacaulenin 26, and their heterosides (27–29). Roots contain secoiridoids 1–3 and 18. LC-ESI TOF MS chromatograms of G. kochiana leaves and roots are given in Figs. 14.4 and 14.5 and in Tables 14.4 and 14.5.
Xanthones
14.2.4 Gentiana asclepiadea L. (Willow Gentian)
Gentiana asclepiadea (Fig. 14.13d) is distributed in Central and Southern Europe from Schwarzwald to Olimp Mountain. It grows in high-mountain pastures and at the edges of forests to the subalpine tops of the mountains. It is also found in beech and spruce forests.
As the roots contain a similar chemical composition to yellow gentian, it is also used in traditional medicine as a remedy for poor appetite, for digestive problems, and for hepatitis A virus infections (Saric 1989; Mihailović et al. 2011). Although G. asclepiadea is very abundant in the flora of Serbia, comprehensive phytochemical and pharmacognostic investigations of plant material have not been carried out. From roots and rhizomes of G. asclepiadea, secoiridoid 1 was isolated together with its 6′-O-β-d-glucoside (30). Underground organs also contained sugars with gentianose being dominant. Unlike yellow gentian, the roots of willow gentian did not contain xanthone compounds. LC-ESI TOF MS chromatogram of G. asclepiadea roots is shown in Fig. 14.6 and in Table 14.6.
Secoiridoids
Aerial parts also contain sugars (fructose , glucose, gentiobiose, gentianose) similar to those in roots. The polyphenolic complex was diverse, being composed of flavonoids and xanthones . LC-ESI TOF MS chromatogram of G. asclepiadea aerial parts is depicted in Fig. 14.7 and in Table 14.7.
C-Glucoflavones such as 11 and 13 and their glycosides 11, 31, 33, and 10 were detected. The second group of γ-pyrone constituents were xanthone C-glucosides, with mangiferin (12) and its two O-glucosides 34 and 35 as the main constituents.
Flavonoids
Xanthones
14.2.5 Gentiana utriculosa L. (Bladder Gentian)
Gentiana utriculosa (Fig. 14.13e) is an annual plant species found in Central Europe, mainly in the mountains of Italy and the Balkan Peninsula (Tutin 1972). According to our knowledge, it is not used in traditional medicine in the central regions of the Balkan Peninsula.
Analysis of the methanolic extract of the aerial parts showed the presence of secoiridoids, flavonoids, and xanthones. LC-ESI TOF MS chromatogram of G. utriculosa aerial parts is presented in Fig. 14.8 and in Table 14.8.
Previous phytochemical investigation of the G. utriculosa led to the isolation of xanthone aglycones 23 and 26, as well as C-glycosides 12, 13, and 15 (Hostettmann and Jacot-Guillarmod 1977). Examination by the authors of G. utriculosa originating from the Mount Tara, West Serbia, revealed xanthone O-glycosides such as 24, 36, and 37, and 4-C-glucoxanthones 12 and 38, the latter being detected for the first time in the genus Gentiana (Janković et al. 2009).
In addition, C-glucoflavones, 11 and 13 and 39, were isolated from the same extracts.
14.2.6 Gentiana punctata L. (Spotted Gentian)
Gentiana punctata (Fig. 14.13f) is a subalpine species of Southeast and Central Europe. The roots of spotted gentian are the officinal substitute for G. lutea , according to Yugoslav Pharmacopoeia IV (Ph. Yug. IV). As the roots and rhizomes contain bitter secoiridoids, they are also used in traditional medicine for the treatment of gastrointestinal tract diseases, as well as in the production of aperitifs (Tasić et al. 2004). G. punctata is an endangered species due to destructive harvesting (Šavikin-Fodulović et al. 2003).
Phytochemical investigations of G. punctata revealed significant differences in the chromatographic profiles of methanolic extracts of roots and aerial parts (Menković et al. 1998). In roots, a secoiridoid complex was dominant among secondary metabolites. Among them, 1 was the most abundant compound. However, flavonoids were not detected, but xanthone aglycon 7 was recorded. LC-ESI TOF MS chromatogram of G. punctata roots is presented in Fig. 14.9 and in Table 14.9.
The most abundant secoiridoid in the aerial parts was 17, while 1 and 2 were also detected together with numerous flavonoid compounds. Xanthones were absent. LC-ESI TOF MS chromatogram of G. punctata aerial parts is presented in Fig. 14.10 and in Table 14.10.
14.3 Genus Gentianella Moench.
The genus contains about 250 species distributed over all continents. Six Gentianella species can be found in Serbia (Jovanović-Dunjić 1973). The main secondary metabolites of the genus are xanthones, flavone C-glucosides, and secoiridoids (Šavikin et al. 2010, Janković 2005). Gentianella species are not used in traditional medicine in the central regions of the Balkan Peninsula .
14.3.1 Gentianella austriaca (A & J Kerner) Holub
Gentianella austriaca is distributed in Southeast Europe and the Central Balkans. It grows on different bedrocks at altitudes of 950–2400 m in mountain and subalpine meadows and pastures, and rocky regions, even in the vegetation of glaciers (Jovanović-Dunjić 1973). The species, collected during flowering at the Mount Kopaonik in Serbia (at ca. 1750 m), was characterized by the presence of three classes of compounds typical for the Gentianaceae, such as secoiridoids, C-glucoflavones , and xanthones. The isolated and identified compounds in the aerial parts of G. austriaca were bellidifolin (40), demethylbellidifolin (41), corymbiferin (42), demethylbellidifolin-8-O-glucoside (43), bellidifolin-8-O-glucoside (swertianolin) (44), corymbiferin-1-O-glucoside (45), veratriloside (46), lanceoside (47), swertisin (48), campestroside (49), together with 1, 12 and 13. Compounds 46 and 47 have been found for the first time in the genus. The dominant compound isolated from the aerial parts was 40 and its 8-O-glycosyl derivatives. The roots also contained all the above-mentioned xanthones , except 49 and the flavonoids. LC-ESI TOF MS chromatogram of G. austriaca aerial parts is presented in Fig. 14.11 and in Table 14.11.
Xanthones
In the course of chemosystematic studies of the family Gentianaceae from Serbia and Montenegro, three additional Gentianella species were also collected at the time of flowering, namely G. albanica (Jav.) Holub and G. crispata (Vis.) Holub at the Mount Hajla, at ca. 1900 m, situated between Montenegro and Serbia (Kosovo), and G. bulgarica (Velen.) Holub on the slopes of the same mountain (at ca. 800 m). The HPLC/DAD (high-performance liquid chromatography with diode array detection) chromatograms of the MeOH (methanol) extracts of the aerial parts of these species indicated considerable similarity with G. austriaca , revealing almost the same constituents (Janković et al. 2005).
14.4 Genus Swertia
Due to the numerous pharmacological properties of its constituents, the genus Swertia has received considerable attention (Šavikin-Fodulovic et al. 2002; Šavikin et al. 2010). Some members of the genus, such as S. japonica , S. chirata, S. hookeri, S. macrosperma , S. petiolata, and S. calycina, have been used in traditional medicine in the Far East for many years. Among their active principles , xanthones (mostly 1,3,7,8- and 1,3,5,8-tetraoxygenated) have special significance because of their various biological activities, e.g., antidepressant , antileukemic, antitumor, antitubercular, choleretic, diuretic, antimicrobial, antifungal, anti-inflammatory, antiviral, cardiotonic, and hypoglycemic activities (Peres et al. 2000; Neerja et al. 2000).
Among the European Swertia species, only S. perennis (Fig. 14.13g) is recognized officially according to Flora Europaea, whereas a provisional status has been assigned to S. punctata Baumg (Tutin 1972). Tan and Vladimirov (2001) claimed that S. punctata is the precisely defined species. S. punctata is also described in flora of Serbia (Jovanović-Dunjić 1973), as the only species of the genus occurring in Serbia.
14.4.1 Swertia Punctata Baumg.
Swertia punctata Baumg. (Fig. 14.13h) is distributed in the Central Balkans. It grows in a zone of mountain wetland pastures, meadows, and turfs, mostly on silicate and serpentine substrates at altitude, between 1500 and 2000 m. Its population in Serbia is scarce and endangered, as reported recently in the Red Book of Serbian Flora (Jovanović 1999). Although several Swertia species are used extensively in traditional medicine, S. punctata is not mentioned in traditional medicine until the present times.
Methanol extracts have been analyzed of the aerial parts and roots of the S. punctata originating from Stara Planina, East Serbia (Menković et al. 2002). LC-ESI TOF MS chromatogram of S. punctata leaves is presented in Fig. 14.12 and in Table 14.12.
Apart from 12 and 13, the compounds isolated from S. punctata are listed below:
1,3,5,8-Tetrasubstituted xanthones
In addition to 40 and 44, the following 1,3,5,8-tetrasubstituted xanthones were identified:
1,3,7,8-Tetrasubstituted xanthones
The roots of S. punctata afforded norswertianin-1-O-glucoside (20), as well as the following 1,3,7,8-tetrasubstituted xanthones (Menković et al. 2002):
14.5 Biological Activity
Due to the diverse chemical composition and the presence of secoiridoids, xanthones, and C-glucoflavones , the numerous pharmacological activities have been demonstrated of Gentianaceae species (Jensen and Schripsema 2002; Neerja et al. 2000; Pinto et al. 2005; Šavikin et al. 2010).
The bitter principles (secoiridoids), the usual constituents of the genus, stimulate secretion of gastric juices and bile, thus aiding appetites and digestion. G. lutea , as the officinal medicinal plant , was investigated extensively and activities, such as increasing salivation, appetite stimulation, and choleretic and immune-stimulating activity were reported (Öztütk et al. 1998, 2006). Gentiopicrin , a dominant compound in the secoiridoid complex, was indicated as the main active compound. Secoiridoids also exhibit several other biological activities. Swertiamarin and sweroside inhibited the growth of Bacillus cereus , B. subtilis , Citrobacter freundii and Escherichia coli , swertiamarin was active against Proteus mirabilis and Serratia marcescens , while sweroside inhibited the growth of Staphylococcus epidermidis (Kumarasamy et al. 2003).
Methanolic extracts of flowers and leaves of Gentiana lutea , together with the isolated compounds mangiferin (12), isogentisin (8), and gentiopicrin (1), were used to investigate the antimicrobial activity. Both extracts and isolated compounds showed antimicrobial activity on a range of Gram-positive and Gram-negative bacteria as well as the yeast Candida albicans (Šavikin et al. 2009). The synergistic activity of the pure compounds may be responsible for the excellent antimicrobial effect of the extracts.
Gentiopicrin (1) has shown spasmolytic activity inhibiting, in a concentration-dependent manner, the spontaneous contractions of isolated guinea pig ileum. Contractions induced by histamine, acetylcholine, BaCL2, and KCL on the ileum were also blocked significantly by this monoterpene glucoside, which suggests that this compound might be interfering with calcium influx into the smooth muscle cells (Rojas et al. 2000).
In a previous study, in vitro experiments showed that mangiferin (12) inhibited the cytotoxic action of ionizing irradiation (doses of 6 and 8 μGy) only on normal resting human PBMC (peripheral blood mononuclear cell), not stimulated for proliferation. Orally consumed G. lutea extract showed the potential to reduce the cytotoxic effect of irradiation on normal human immunocompetent cells PBMC of some healthy people, without changing the susceptibility of malignant cells to be destroyed by irradiation (Menković et al. 2010).
As reviewed by Neerja et al. (2000), bellidifolin (40), methylbellidifolin (51), methylswertianin (54), and mangiferin (12) isolated from the Swertia species exhibited various biological effects such as hypoglycemic, hepatoprotective, antituberculous, antioxidant, antimalarial, and anti-inflammatory activities. The xanthones, gentiacaulenin (26) and gentiakochianin (25), are responsible for antihypertensive activity, exerting a vasodilator action on in vitro aortic rings, probably linked to the blocking of the ryanodine-sensitive Ca++ channels (Chericioni et al. 2003).
Inhibition has been observed of type A and type B monoamine oxidases by a number of xanthones (Suzuki et al. 1980, 1981). Diethyl ether extracts of G. kochiana as well as gentiacaulenin (26) and gentiakochianin (25) were tested for CNS (central nervous system) pharmacological activity in rodents (Tomić et al. 2005). Extracts and 26 strongly inhibited rat microsomal MAO (monoamine oxidase) A. Examinations of behavior on mice showed that 10-day s.c. administration of the extract (20 mg/kg) decreased significantly immobility score in a forced swimming test and strongly inhibited ambulation and stereotypy in an open-field test. Studies suggest some antidepressant therapeutic potential of G. kochiana that is presumably connected to the action of 26.
Xanthones 25 and 26 were also identified as the active principles responsible for in vitro antiglioma action of ether and methanolic extracts of G. kochiana (Isakovic et al. 2008). These compounds induced cell cycle arrest in G2/M and G0/G1 phases, respectively, in both C6 rat glioma and U251 human glioma cell lines. Both xanthones reduced mitochondrial membrane potential and increased the production of reactive oxygen species in glioma cells, but only the effects of 25 were pronounced enough to cause caspase activation and subsequent apoptotic cell death. The assessment of structure-activity relationship showed that dihydroxylation at positions 7, 8 of the xanthonic nucleus is the key structural feature responsible for the ability of gentiakochianin to induce microtubule-associated G2/M cell blockage and apoptotic cell death in glioma cells.
Hudecová et al. (2012) showed that G. asclepiadea exerts antioxidant activity and enhances DNA repair of hydrogen peroxide- and silver nanoparticle-induced DNA damage. The same study also showed antioxidant, antigenotoxic, and biomodulatory effects of G. asclepiadea extracts on various cells (including lymphocytes and HEK 293 cells) exposed to different agents such as H2O2, Zeocin, and AgNPs (silver nanoparticles).
The aerial parts of Gentianella austriaca were evaluated for their antioxidative activity and protective properties on irradiated human peripheral blood lymphocytes in vitro (Leskovac et al. 2007). Aqueous ethanolic extracts showed protective effects, decreasing the incidence of radiation-induced micronuclei by 35.56 %, and significantly reduced lipid peroxidation for 30.88 %. The radioprotective effects of the water-soluble xanthones demethylbellidifolin (41), demethylbellidifolin-8-O-glucoside (43), bellidifolin-8-O-glucoside (44), and the flavonoid swertisin (48) were also reported (Jankovic et al. 2008). Among the compounds examined, the highest reduction by 27.92 % in the incidence of micronuclei was observed in irradiated lymphocytes treated with swertisin (48).
In addition, isovitexin (15), the co-occurring constituent of G. lutea leaves, exhibits considerable antioxidative and hypoglycemic effects. The potential antioxidative effect of the extract of the leaves of G. lutea could be assigned to xanthones and flavonoids, presumably mangiferin (12) and isoorientin (13), respectively. It is well known (Rice-Evans et al. 1995) that the potential of flavonoids and xanthones to exert antioxidative effects is strongly dependent on their structure and the substituents of the heterocyclic and B rings. As far as the antiradical activity is concerned, the following structural features are essential:
-
(a)
3′,4′-Dihydroxy pattern (ring B)
-
(b)
2,3-double bond conjugated with keto group (ring A)
-
(c)
3,5-Dihydroxy substitution (ring A)
-
(d)
Free 7-OH; it was established that glycosylation in positions 3, 5, and 7 reduces the activity.
The structure of isoorientin (13) fulfills most of the above conditions with ortho-3′,4′-OH groups, 5-OH and 7-OH, as well as a 2,3-double bond conjugated with the keto group. This could explain considerable antioxidative activity of 13. 3′ and 4′-O-glucosides of 13, lacking free ortho-3′,4′-OH groups that exhibit rather small inhibitory capacity (<1 %), (Burda and Oleszek 2001). In swertisin (48), free OH groups are only at C-4′ i C-5, whereas 7-OH is methylated, causing much lower activity in 48 (3 %) in comparison with that in 13 (66 %). At the same time, the considerable antioxidative activity of mangiferin (12) could be explained by the structural features similar to those in isoorientin (Krstić-Milošević 2008).
Based on the comparison of pharmacologic effects of the main components in the extracts of G. lutea leaves, one could expect antidiabetic, hepatoprotective, and anti-inflammatory effects. Thus, the continuation would be justified of the chemical investigation of this extract, aimed to discover a new source of drugs for use in phytotherapy. The use of yellow gentian leaves in the therapy instead of roots could have a protective effect on this species endangered by overexploitation. In addition, in the ethnomedicine of Turkey, as well as in the Indian medicine Ayurveda, Gentiana olivieri , possessing a similar chemical profile to G. lutea, is used as tonic and bitter as well as for its antidiabetic, appetizer, and antipyretic effects (Sezik et al. 2005, Chopra et al. 2006, Mansoor and Malghani 1999).
Recently, Turkish authors have proved the hypoglycemic activity of the extracts of this species in which 13 was a dominant constituent, and at the same time, its hepatoprotective effect was evaluated (Orhan et al. 2003).
Similarly, in the Chinese province of Mongolia, the people use a plant “guixincao” in the form of a tea to cure colds, to clean blood by removing toxins and pathogens, as well as a diuretic (Min-Hui et al. 2010). This plant, identified as Gentianella acuta (Michaux.) Hulten, exhibits the chemical profile rather similar to that of G. austriaca with demethylbellidifolin , bellidifolin , and the corresponding heterosides being dominant.
Moreover, according to the chemical composition, S. punctata could be attractive as a source of medicinal raw material, but since its population is small, efforts are now concentrated on determining alternative ways for biomass production.
14.6 Experimental Design
14.6.1 Plant Material
For analysis, aerial parts and roots were collected from all species investigated. G. lutea was collected on the Mount Suvobor 750 m, Serbia; G. dinarica on the Mount Tara 1300 m, Serbia; G. kochiana on the Mount Komovi 2100 m, Montenegro; G. asclepiadea on the Mount Hajla 1900 m, Montenegro; and G. utriculosa on the Mount Tara (1100 m), Serbia. Four species of genus Gentianella were examined in the present studies. G. albanica and G. crispata were collected on the Mount Hajla at ca. 1900 m situated between Montenegro and Serbia (Kosovo), G. bulgarica on the slopes of the same mountain at ca. 800 m, and G. austriaca at Mount Kopaonik in Serbia at ca. 1750 m. S. punctata was collected on Stara mountain (1900 m), Serbia.
14.6.2 Chromatographic Techniques
A combination of different preparative chromatographic techniques was applied to isolate pure compounds. The analogous basic separation scheme, shown in Fig. 14.14 for Swertia punctata , was applied to isolate pure compounds from all extracts examined.
The spectra were recorded with the following instruments: IR, Perkin-Elmer FT-IR spectrometer 1725 X; 1H and 13C NMR 1D and 2D NMR, Varian Gemini 2000 (200 MHz for 1H), and Bruker AMX 500 (500 MHz for 1H); UV, G113AA HP 8543 advanced UV–Vis spectrometer; DCIMS (150 eV, isobutane), Finnigan MAT mass spectrometer 8230, double focusing (BE geometry); ESIMS (a sample, dissolved in MeOH–H2O, 1:1) Finnigan MAT 900, double focusing (EB geometry) equipped with a Finnigan MAT electrospray interface; optical rotations, Perkin-Elmer 141 MC polarimeter; melting points (not corrected), Boetius PHMK apparatus; analytical HPLC, Hewlett Packard HPLC model 1090, DAD detector (HP 1040), column, Lichrospher RP-18 (5 ı̀), 250 × 4 mm I.D. (Merck); preparative medium pressure chromatography (MPLC), Lobar column (silica gel Si 60, size A or B); dry-column flash chromatography (DCFC), silica gel Si 60; MN polyamide DC 6; TLC, 0.2 mm, silica gel 60 F 254 Merck, detection under UV or by heating after spraying with 50 % H2SO4; column chromatography (CC), polyamide-6-powder (polycaprolactam); Sephadex LH-20; elemental C,H-analysis, combustion method (Fig. 14.14).
14.6.2.1 LC-ESI TOF MS Analysis of MeOH Extracts
Air-dried plant material (0.5 g) was extracted with MeOH (10 ml) at room temperature for 48 h. The solvent was removed under vacuum at room temperature. Before the analysis, the extract was dissolved in MeOH and the concentration was adjusted to ca. 10 mg/ml, followed by filtration through a Teflon Millipore filter HV, with a pore size 0.45 µm.
-
1.
Injection volume: 5 μl.
-
2.
Instrument: Agilent MSD ESI TOF coupled with Agilent 1200 series RR, liquid chromatography.
-
3.
Column: LiChrospher 100 RP 18e, 150 × 4.0 mm i.d. 5.0 μm.
-
4.
Mobile phase: A (water + 0.2 % HCOOH) + B (MeCN).
-
5.
Elution: combination of gradient and isocratic modes according to following scheme:
Time (min)
Phase A (%)
Phase B (%)
0
98
2
5
90
10
18
90
10
20
85
15
25
85
15
30
70
30
40
30
70
50
30
70
51
98
2
55
98
2
-
6.
Flow rate: 0.995 ml/min.
-
7.
MSD conditions: drying gas (N2) flow 12 l/min; nebulizer pressure 45 psig; drying gas temperature 350o; capillary voltage, 4000 V; fragmentor voltage, 140 V; skimmer, 60 V; Oct RF voltage 250 V; positive mode, mass range m/z 100–2500; 10,000 transients/scan.
14.7 Conclusions
The limited selection of bioactive plant constituents of some Gentiana, Gentianella, and Swertia species and the therapeutic applications described here give a general idea of the progress achieved over the last two decades. These achievements have been possible, in part, thanks to the development of techniques in separation and spectroscopy. LC DAD-ESI TOF MS chromatograms of plant extracts are presented and discussed.
Among numerous bioactive extracts, those of G. lutea leaves emerge as very promising since one could expect antidiabetic, hepatoprotective, and anti-inflammatory effects. Thus, the continuation is justified of the chemical investigation of this extract, aimed to discover a new source of drugs used in phytotherapy. The use of yellow gentian leaves instead of roots in therapy could have a protective effect on this species endangered by overexploitation. Moreover, according to its chemical composition, Swertia punctata could be attractive as a source of medicinal raw material, but since its population is small, efforts should be focused in finding alternative ways for biomass production.
References
Blumenthal M (1998) The complete German commission E monographs. American Botanical Council, Austin
Burda SW, Oleszek W (2001) Antioxidants and antiradical activity of flavonoids. J Agric Food Chem 49:2774–2779
Chericioni S, Testai L, Calderone V, Flamini G, Nieri P, Morelli I, Martinotti E (2003) The xanthones gentiacaulenin and gentiakochianin are responsible for the vasodilator action of the roots of Gentiana kochiana. Planta Med 69:767–770
Chopra RN, Nayar SL, Chopra IC, Asolkar LV, Kakkar KK, Chakre OJ, Varma BS (2006) Glossary of Indian medicinal plants. Council of Scientific and Industrial Research, New Delhi, p 330
European Pharmacopoeia (2011) 7.0. Council of Europe, Strasbourg Cedex, France.
Flora Europea Online database at the Royal Botanic Garden Edinburgh (2005) http://rbg-web2.rbge.org.uk
Hostettmann K, Jacot-Guillarmod A (1977) Xanthones et C-glucosides flavoniques du genre Gentiana (section Cyclostigma). Phytochemistry 16:481–482
Hostettmann K, Bellmann G, Tabacchi R, Jacot-Guillarmod A (1973) Contribution à la phytochimie du genre Gentiana III. Etude des composés flavoniques et xanthoniques dans les feuilles de Gentiana lutea L. (2me communication). Helvetica Chimica Acta 56:3050–3054
Hudecová A, Kusznierewicz B, Hašplová K, Huk A, Magdolenová Z, Miadoková E, Gálová E, Dušinská M (2012) Gentiana asclepiadea exerts antioxidant activity and enhances DNA repair of hydrogen peroxide- and silver nanoparticles-induced DNA damage. Food Chem Toxicol 50:3352–3359
Isaković A, Janković T, Lj Harhaji, Kostić-Rajačić S, Nikolić Z, Vajs V, Trajković V (2008) Antiglioma action of xanthones from Gentiana kochiana: mechanistic and structure-activity requirements. Bioorg Med Chem 16:5683–5694
Janković T (2005) Comparative study of chemical constituents of Gentianella plant species, Ph.D. thesis, Faculty of Chemistry, University of Belgrade, Serbia
Janković T, Krstić D, Aljančić I, Šavikin-Fodulović K, Menković N, Vajs V, Milosavljević S (2005) Xanthones and C-glucosides from the aerial parts of four species of Gentianella from Serbia and Montenegro. Biochem Syst Ecol 33:729–735
Janković T, Šavikin K, Menković N, Aljančić I, Leskovac A, Petrović S, Joksić G (2008) Radioprotective effects of Gentianella austriaca fractions and polyphenolic constituents in human lymphocytes. Planta Med 74:736–740
Janković T, Krstić-Milošević D, Aljančić I, Šavikin K, Menković N, Radanović D, Milosavljević S (2009) Phytochemical re-investigation of Gentiana utriculosa. Nat Prod Res 23:466–469
Jensen SR, Schripsema J (2002) Chemotaxonomy and pharmacology of Gentianaceae. In: Struwe L, Albert V (eds) Gentianaceae-systematics and natural history. Cambridge University Press, Cambridge, pp 573–631
Jovanović S (1999) Swertia perennis L. In: Stevanović V (ed) The Red Book of Flora of Serbia 1. Extinct and Critically Endangered Taxa. Ministry of Environment of the Republic of Serbia, Faculty of Biology, University of Belgrade, Institute for the Protection of Nature of the Republic of Serbia, Serbia, pp 261–263
Jovanović-Dunjić R (1973) Gentianaceae. In: Josifović M (ed) Flora of Serbia, vol V. SANU, pp 426–433
Krstić-Milošević D (2008) Chemical investigation of pharmacologically active secondary metabolites of some species from genus Gentiana. Ph.D. thesis, Faculty of Chemistry, University of Belgrade
Kumarasamy Y, Nahar L, Cox PJ, Jaspars M, Sarker SD (2003) Bioactivity of secoiridoid glycosides from Centaurium erythraea. Phytomedicine 10:344–347
Leskovac A, Joksić G, Janković T, Šavikin K, Menković N (2007) Radioprotective properties of the phytochemically characterized extracts of Crataegus monogyna, Cornus mas and Gentianella austriaca on human lymphocytes in vitro. Planta Med 73:1169–1175
Manganelli RU, Chericoni S, Baragatti B (2000) Ethnopharmacobotany in Tuscany: plants used as antihypertensives. Fitoterapia 71:95–100
Mansoor AM, Malghani MA (1999) Biological efficacy of the extract and pure compound of Gentiana olivieri. Pak J Biol Sci 2:807–808
Menković N, Šavikin-Fodulović K, Vinterhalter B, Vinterhalter D, Grubišić D (1998) Investigation of secoiridoids in Gentiana punctata grown in nature and cultured in vitro. Pharma Pharmacol Lett 8:110–111
Menković N, Šavikin-Fodulović K, Čebedžić R (1999) Investigation of the activity of Gentiana lutea extracts against Mycobacterium bovis. Pharma Pharmacol Lett 9:74–75
Menković N, Šavikin-Fodulović K, Savin K (2000) Chemical composition and seasonal variations in the amount of secondary compounds in Gentiana lutea leaves and flowers. Planta Med 66:178–180
Menković N, Šavikin-Fodulović K, Bulatović V, Aljančić I, Juranić N, Macura S, Vajs V, Milosavljević S (2002) Xanthones from Swertia punctata. Phytochemistry 61:415–420
Menkovic N, Juranic Z, Stanojkovic T, Raonic-Stevanovic T, Šavikin K, Zdunić G, Borojevic N (2010) Radioprotective activity of Gentiana lutea extract and mangiferin. Phytotherapy Res 24:1693–1696
Mihailović V, Vuković N, Nićiforović N, Solujić S, Mladenović M, Mašković P, Stanković M (2011) Studies on the antimicrobial activity and chemical composition of the essential oils and alcoholic extracts of Gentiana asclepiadea L. J Med Plants Res 5:1164–1174
Min-Hui L, Li-She Z, Hui-Yong F, Xiao-Ling S, Na Z (2010) Quantification of xanthones in a Mongolian health tea using high-performance liquid chromatography. J Med Plants Res 4:1704–1707
Neerja P, Jain DC, Bhakuni RS (2000) Phytochemicals from genus Swertia and their biological activities. Ind J Chem 39B:565–586
Orhan DD, Aslan M, Aktay G, Ergun E, Yesilada E, Ergun F (2003) Evaluation of hepatoprotective effect of Gentiana olivieri herbs on subacute administration and isolation of active principle. Life Sci 72:2273–2283
Öztütk N, Herekman-Demir T, Öztütk Y, Bozan B, Baser KHC (1998) Choleretic activity of Gentiana lutea ssp. symphyandra in rats. Phytomed 5:283–288
Öztürk N, Korkmaz S, Öztürk Y, Başer KHC (2006) Effects of gentiopicroside, sweroside and swertiamarine, secoiridoids from gentian (Gentiana lutea ssp. symphyandra) on cultured chicken embryonic fibroblasts. Planta Med 72:289–294
Peres M, Tanus JN, de Fernando OF (2000) Tetraoxygenated naturally occurring xanthones. Phytochem 55:683–710
Pharmacopoea Yugoslavica IV (1984)
Pinto MM, Sousa ME, Nascimento MSJ (2005) Xanthone derivatives: new insights in biological activities. Curr Med Chem 12:2517–2538
Pontus S, Michael AP, Chaim I (2006) Use of Gentiana lutea extracts as an antimicrobial agent. European Patent EP1663271
Rice-Evans C, Miller N, Bolwell PG, Bramley PM, Pridham JB (1995) The relative antioxidant activity of plant derived polyphenolic flavonoids. Free Radical Res 22:375–383
Rojas A, Bah M, Rojas JI, Gutiérrez DM (2000) Smooth muscle relaxing activity of gentiopicroside isolated from Gentiana spathacea. Planta Med 66:765–767
Sarić MR (1989) Medicinal plants of SR Serbia, vol. DXCVIII. Serbian Academy of Sciences and Arts, Belgrade (in Serbian), pp 153–154
Šavikin-Fodulovic K, Jankovic T, Krstic D, Menkovic N (2002) Xanthone compounds in some Gentianaceae species growing in Serbia and Montenegro. In: Majumdar DK, Govil JN, Singh VK (eds) Phytochemistry and pharmacology II. Series recent progress in medicinal plants, vol 8. SCI TCH pub., Houston, pp 371–401
Šavikin-Fodulović K, Janković T, Krstić D, Menković N (2003) Xanthone compounds in some Gentianaceae species grown in Serbia and Montenegro. In: Majumdar DK, Govil JN, Singh VK (eds) Recent progress in medicinal plants. Phytochem Pharmacol II, vol 8. Studium Press, LLC USA, pp 371–401
Šavikin K, Menković N, Zdunić G, Stević T, Janković T (2007) Antimicrobial activity of Gentiana lutea L. extracts and isolated compounds mangiferin, isogentisin and gentiopicrin. Planta Medica 09, 57th GA Congress, Graz, Austria
Šavikin K, Menkovic N, Zdunic G, Stevic T, Radanovic D, Jankovic T (2009) Antimicrobial activity of Gentiana lutea L. extracts. J Biosciences 64:339–342
Šavikin K, Janković T, Krstić-Milošević D, Menković N, Milosavljević S (2010) Secondary metabolites and biological activities of some Gentianaceae species from Serbia and Montenegro. In: Gupta VK, Taneja SC, Gupta BD (eds) Comprehensive bioactive natural products, vol 6. Extraction, isolation and characterization. Studium Press, LLC, USA, pp 323–340
Sezik E, Aslan M, Yesilada E, Ito S (2005) Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay-directed fractionation techniques. Life Sci 76:1223–1238
Suzuki O, Katsumata Y, Oya M, Chari VM, Klapfenberg R, Wagner H (1980) Inhibition of type A and type B monoamine oxidase by isogentisin and its 3-O-glucoside. Planta Med 39:19–23
Suzuki O, Katsumata Y, Oya M, Chari VM, Vermes B, Wagner H, Hostettmann K (1981) Inhibition of type A and type B monoamine oxidase by naturally occurring xanthones. Planta Med 42:17–21
Tan K, Vladimirov V (2001) Swertia punctata Baumg. (Gentianaceae) in Bulgaria. Bocconea 13:461–466
Tasić S, Šavikin–Fodulović K, Menković N (2004) Gentiana lutea. In: Guide through medicinal plants World Agency “Valjevac”, Valjevo, Serbia (in Serbian)
Tomić M, Tovilović G, Butorović B, Krstić D, Janković T, Aljančić I, Menković N (2005) Neuropharmacological evaluation of diethylether extract and xanthones of Gentiana kochiana. Pharmacol Biochem Behavior 81:535–542
Tucakov J (1996) Lečenje biljem-fitoterapija. Rad, Beograd, pp 1–274
Tutin TG (1972) Gentiana L. In: Tutin TG, Heywood VH, Burges NA, Moore DM, Valentine DH, Walters SM, Webb DA (eds) Flora Europaea, vol 3. Cambridge University Press, Cambridge, pp 59–67
Wagner H, Bladt C, Zgainski EM (1983) Plant drug analysis. Springer, Berlin, pp 125–131
Acknowledgments
The authors thank the Ministry of Science, Education and Technological Development of Serbia for the financial support, project No. 172053. They also thank Slavoljub Tasić, the author of the photographs, and Dejan Pljevljakušić for the technical assistance in preparing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Šavikin, K. et al. (2015). Bioactive Secondary Metabolites in Several Genera of Gentianaceae Species from the Central Regions of the Balkan Peninsula. In: Rybczyński, J., Davey, M., Mikuła, A. (eds) The Gentianaceae - Volume 2: Biotechnology and Applications. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54102-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-54102-5_14
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54101-8
Online ISBN: 978-3-642-54102-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)